TAFINLAR (Dabrafenib) Capsules

What is Tafinlar (Dabrafenib)
Tafinlar is a cancer medication that interferes with the growth and spread of cancer cells in the body. Tafinlar is used to treat a certain type of metastatic melanoma ( skin cancer that has spread to other parts of the body)

TAFINLAR

Drug Manufacturer / Marketeer :

M/s GlaxoSmithKline


Available as:

50 mg and 70mg capsules

Indications:
Tafinlar is indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA approved test.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:

  • Tafinlar 50 mg (dark red capsule) is supplied in bottles of 120.
  • Tafinlar 75 mg (dark pink capsule) is supplied in bottles of 120.

Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.

How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s GlaxoSmithKline .

Assistance Cell in India:
For ONCOLOGY DRUG: TAFINLAR (Dabrafenib) Capsules 50MG and 70MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.